Novavax, Inc.
NVAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$202 | $107 | $519 | -$81 |
| Dep. & Amort. | $7 | $8 | $8 | $13 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9 | $10 | $10 |
| Change in WC | $166 | -$240 | -$740 | -$49 |
| Other Non-Cash | $138 | -$10 | $17 | -$66 |
| Operating Cash Flow | $108 | -$127 | -$186 | -$173 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$235 | $0 | -$115 | -$384 |
| Inv. Sales/Matur. | $101 | $112 | $43 | $338 |
| Other Inv. Act. | $0 | -$0 | $0 | $193 |
| Investing Cash Flow | -$137 | $111 | -$73 | $144 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $42 | -$1 | -$2 | -$3 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $1 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$5 | -$1 |
| Financing Cash Flow | $42 | -$1 | -$7 | -$3 |
| Forex Effect | $1 | $8 | -$1 | -$11 |
| Net Chg. in Cash | $14 | -$9 | -$267 | -$43 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $264 | $278 | $545 | $589 |
| End Cash | $279 | $269 | $278 | $545 |
| Free Cash Flow | $106 | -$128 | -$187 | -$175 |